Navigation Links
Lung Cancer Alliance Commends NCCN on Screening Guidelines
Date:3/14/2008

WASHINGTON, March 14 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) called the new screening guidelines announced by the National Comprehensive Cancer Network (NCCN) "a positive step in the right direction that will encourage those at high risk for lung cancer to fully investigate their option of getting a CT scan."

LCA President Laurie Fenton Ambrose said that lung cancer will continue to kill more people each year than all the other major cancers combined until more at risk people realize the urgency of being diagnosed early.

Currently only 16% of lung cancer patients are being diagnosed at an early and curable stage.

To date only CT scanners can detect lung cancers early - a fact that no one disputes - but the statistical debate goes on.

Fenton Ambrose pointed out that similar statistical debates held up mammograms for years until Congress stepped in. Debates still rage over mammograms for women under the age of 50 and PSA testing for prostate cancer in men.

The debate carried into the NCCN meeting earlier this month and the panel reviewing lung cancer was unable to reach a consensus on routine CT scans. However, NCCN issued a compromise statement recommending that people at high risk for lung cancer should participate in a clinical trial on CT screening or go to a center with expertise in all areas of lung cancer diagnosis and treatment to discuss the potential risks and benefits of a screening CT.

"This is exactly what we have been saying for the past two years," said Fenton-Ambrose, "and we are pleased that NCCN takes this position as well."

The only national CT trial still accepting participants is the International Lung Cancer Early Action Program (I-ELCAP).

That program, which was launched in 1992, has scanned over 30,000 people at high risk for lung cancer in 26 states and 8 foreign countries. The results of its first 13 years were published in the New England Journal of Medicine in 2006 and showed that CT scanning could detect lung cancer at its earliest stages, and those treated promptly had 10-year survival rates of 92%.

Currently, without screening, the national 5-year survival rate for lung cancer is 15%.

In 2002, the National Cancer Institute began a trial comparing CT scans to chest x-rays and stopped recruitment two years later. Those patients will be followed until 2009 but results are not expected to be published until 2012.

"Another 850,000 people will die of lung cancer by that time. We cannot continue to ignore the rapid advances in imaging that can offer those at high risk the chance of an early diagnosis when the disease is still curable," she said.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer. Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

Media Contact:

Kay Cofrancesco

kay@lungcanceralliance.org

202-463-2080


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
2. Anti-Cancer Drug CYT997 Update
3. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
5. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
6. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
7. GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
8. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
9. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
10. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
11. Thomson Healthcare Cancer Profiler Used in Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Mass. , February 23, 2017 - ...   ... Honoring Rare Disease Day Open to All at http://www.shire.com/RareCount   ... today announced the launch of ,Rare Count, in honor of Rare ... diseases, which equates to nearly one in 20 global citizens. It ...
(Date:2/22/2017)... , Feb. 22, 2017 IRIDEX Corporation (Nasdaq: ... release financial results for the fourth quarter and 2016 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:2/22/2017)... , Feb. 22, 2017 Summary ... deals and agreements entered into by the worlds leading ... Description The Global Spinal Cord Partnering Terms ... to partnering deals and agreements entered into by the ... partnering deals - Top deals by value ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The Waismann Method® is providing ... who have recently fallen victim to America’s opioid epidemic. Now, opiate dependent individuals can ... they are free from the shame, stigma, and harmful labeling believed to ...
(Date:2/22/2017)... TX (PRWEB) , ... February ... ... Risk Adjustment solution leverages advanced data analytics to accurately understand each Medicare ... proper reimbursement for a given population. This new solution helps transform the ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified ... from the mouth into the bloodstream. Far outpacing the absorption speed ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, ... is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... of neurosurgeons in Michigan performing minimally invasive back surgery that often results in ...
(Date:2/22/2017)... ... , ... The SeniorCare Investor will host an important webinar— Seniors Housing M&A: ... 1:00 PM ET. A recording of the webinar will also be made available following ... you want to find out what really happened in the seniors housing and care ...
Breaking Medicine News(10 mins):